Posted by Michael Wonder on 05 Dec 2016
Hepatitis C drugs Australia's most expensive, cost taxpayers $1 billion in four months
5 December 2016 - Hepatitis C medications approved in March this year have already topped the list of Australia's most expensive drugs, costing the taxpayer $1 billion.
The latest figures have outlined 10 most prescribed and most expensive drugs on the Pharmaceutical Benefits Scheme (PBS) in the past year.
The figures are particularly notable due to the introduction of two new hepatitis C drugs, which were introduced to the PBS in March.
